Generic Portal
— Research Explorer
- 2005
Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?
Vogt, L., Navis, G. & de Zeeuw, D., 2005, In: Journal of the American Society of Nephrology. 16, Suppl. 1, p. S53-S57Research output: Contribution to journal › Article › Academic › peer-review
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial
Vogt, L., Navis, G., Köster, J., Manolis, A. J., Reid, J. L. & de Zeeuw, D., 2005, In: Journal of hypertension. 23, 11, p. 2055-2061Research output: Contribution to journal › Article › Academic › peer-review
- 2004
Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction
Vogt, L., Laverman, G. D., Dullaart, R. P. F. & Navis, G., 2004, In: Nephrology, dialysis, transplantation. 19, 1, p. 5-8Research output: Contribution to journal › Editorial › Academic › peer-review
Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt, L., Kocks, M. J. A., Laverman, G. D. & Navis, G., 2004, In: Minerva medica. 95, 5, p. 395-409Research output: Contribution to journal › Article › Academic › peer-review
- 2003
The COOPERATE trial
Vogt, L., Laverman, G. D., de Zeeuw, D. & Navis, G., 2003, In: Lancet. 361, 9362, p. 1055-1056Research output: Contribution to journal › Comment/Letter to the editor › Academic
- 2002
Renoprotection: a matter of blood pressure reduction or agent-characteristics?
Vogt, L., Navis, G. & de Zeeuw, D., 2002, In: Journal of the American Society of Nephrology. 13, Suppl. 3, p. S202-S207Research output: Contribution to journal › Article › Academic › peer-review
ID: 103492